Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (451-460 of 645) with videos related to

Pageof 65
Sort By:
Circulation|May 5, 2025
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future DirectionsMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Heart Journal|February 26, 2009
The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failureRafael Vazquez, Antoni Bayes-Genis, Iwona Cygankiewicz, et al.
European Journal of Heart Failure|June 16, 2023
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trialAntoni Bayes-Genis, Josep Lupón, Elena Revuelta-Lopez, et al.
American Journal of Translational Research|June 18, 2014
Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regenerationCarolina Soler-Botija, Juli R Bagó, Aida Llucià-Valldeperas, et al.
Theranostics|July 14, 2022
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine modelMarta Monguió-Tortajada, Cristina Prat-Vidal, Daina Martínez-Falguera, et al.
The American Journal of Cardiology|March 31, 2009
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
Journal of Clinical Medicine|February 15, 2022
Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular MortalityGiosafat Spitaleri, Elisabet Zamora, German Cediel, et al.
European Journal of Heart Failure|July 30, 2015
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?Susan Stienen, Khibar Salah, Luc W M Eurlings, et al.
Psychotherapy and Psychosomatics|October 11, 2018
Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients: A Cohort AnalysisCrisanto Diez-Quevedo, Josep Lupon, Marta de Antonio, et al.
Pageof 65

Showing results (451-460 of 645) with videos related to

Sort By:
Pageof 65
Circulation|May 5, 2025
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future DirectionsMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Heart Journal|February 26, 2009
The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failureRafael Vazquez, Antoni Bayes-Genis, Iwona Cygankiewicz, et al.
European Journal of Heart Failure|June 16, 2023
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trialAntoni Bayes-Genis, Josep Lupón, Elena Revuelta-Lopez, et al.
American Journal of Translational Research|June 18, 2014
Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regenerationCarolina Soler-Botija, Juli R Bagó, Aida Llucià-Valldeperas, et al.
Theranostics|July 14, 2022
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine modelMarta Monguió-Tortajada, Cristina Prat-Vidal, Daina Martínez-Falguera, et al.
The American Journal of Cardiology|March 31, 2009
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
Journal of Clinical Medicine|February 15, 2022
Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular MortalityGiosafat Spitaleri, Elisabet Zamora, German Cediel, et al.
European Journal of Heart Failure|July 30, 2015
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?Susan Stienen, Khibar Salah, Luc W M Eurlings, et al.
Psychotherapy and Psychosomatics|October 11, 2018
Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients: A Cohort AnalysisCrisanto Diez-Quevedo, Josep Lupon, Marta de Antonio, et al.
Pageof 65